ロード中...
The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study
BACKGROUND: In 2013 American College of Cardiology and the American Heart Association released a guideline on the management of atherosclerotic cardiovascular disease (ASCVD) including a composite of death from CVD, non-fatal myocardial infarction, or non-fatal stroke (hard CVD). This guideline reco...
保存先:
| 出版年: | J Transl Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7789723/ https://ncbi.nlm.nih.gov/pubmed/33407576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02686-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|